AI drug discovery firms are companies that apply artificial intelligence and machine learning to accelerate and improve the discovery and development of new therapeutics. Rather than a single company, this refers to a category of organizations that build models, platforms, and tools to predict molecular properties, design novel compounds, optimize clinical trial design, and de-risk R&D pipelines. These firms typically work with pharmaceutical and biotech partners to shorten timelines, reduce costs, and increase the probability of success in drug development.
No use cases found for this company.
Browse all companies